Clinical Trial Update: XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery

View source ↗

Summary

This clinical trial update reports completion of XIENCE V EXCEED evaluating catheterization lab endpoints and delivery for the XIENCE V everolimus-eluting stent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atherosclerosis, Coronary Artery Disease | Status: COMPLETED